Acceleron Pharma Inc - Company Profile
Powered by
All the data and insights you need on Acceleron Pharma Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Acceleron Pharma Inc Strategy Report
- Understand Acceleron Pharma Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Acceleron Pharma Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
29 Sep 2021 | Merck Acquires Acceleron Pharma | Acquisition |
Merck & Co Inc
|
Acceleron Pharma Inc |
29 Jun 2020 | Acceleron Pharma Raises USD517.5 Million in Pubic Offering of Shares | Equity Offering | - |
Acceleron Pharma Inc |
20 Dec 2019 | Acceleron Pharma Enters into Licensing Agreement with Fulcrum Therapeutics | Licensing Agreement |
Acceleron Pharma Inc
|
Fulcrum Therapeutics Inc
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer